Maturation of recombinant hepatitis B virus surface antigen particles

Human Vaccines

Volumn 2, Issue 4, 2006, Pages 174-180

  Zhao, Qinjian ^a,b   Wang, Yang ^a   Freed, Daniel ^b   Fu, Tong Ming ^b   Gimenez, Juan A ^a   Sitrin, Robert D ^a   Woshabaugh, Michael W ^a  

^a Department of Bioprocess and Bioanalytical Research ^*  (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Atomic force microscopy; Conformation flexibility; Cross linking; Lipoprotein particles; Stopped flow; Unfolding

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; PROTEIN SUBUNIT; RECOMBINANT ANTIGEN;

ANTIGENICITY; ARTICLE; ATOMIC FORCE MICROSCOPY; CROSS LINKING; DISULFIDE BOND; HYDROPHOBICITY; IMMUNOGENICITY; MORPHOLOGICAL ADAPTATION; PROTEIN DENATURATION; PROTEIN PROCESSING; PROTEIN STRUCTURE;

EID: 33748882131     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.2.4.3015     Document Type: Article

References (34)

1. Hilleman MR. Overview of the pathogenesis, prophylaxis, and therapeusis of viral hepatitis B, with focus on reduction to practical applications. Vaccine 2001; 19:1837-48.
2. Hilleman MR. Critical overview and outlook: Pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. Vaccine 2003; 21:4626-49.
3. McAleer WJ, Buynak EB, Maigerter RZ, Wampler DE, Miller WJ, Hilleman MR. Human hepatitis B vaccine from recombinant yeast. Nature 1984; 307:178-80.
4. Valenzuela P, Medina A, Rutter WJ, Hammerer G, Hall BD. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 1982; 298:347-50.
5. Huovila AP, Eder AM, Fuller SD. Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment. J Cell Biol 1992; 118:1305-20.
6. Wampler DE, Lehman ED, Boger J, McAleer WJ, Scolnick EM. Multiple chemical forms of hepatitis B surface antigen produced in yeast. Proc Nat Acad Sci 1985; 82:6830-4.
7. Guerrero E, Gavilanes F, Peterson DL. Model for the protein arrangement in HBsAg particles based on physical and chemical studies. In; Zuckerman AJ, ed. Viral Hepatitis and Liver Disease. New York: Alan R Liss Inc., 1988:606-13.
8. Hauser P. Induction of neutralizing antibodies in chimpanzees and in humans by a recombinant yeast-derived hepatitis B surface antigen particle. In: Zuckerman AJ, ed. Viral Hepatitis and Liver Disease. New York: Alan R Liss Inc., 1988:1031-7.
9. Mishiro S, Imai M, Takahashi K, Machida A, Gotanda T, Miyakawa Y, Mayumi M. A 49,000-Dalton polypeptide bearing all antigenic determinants and full immunogenicity of 22-nm Hepatitis B surface antigen particles. J Immunol 1980; 124:1589-93.
10. Zhao Q, Guo HH, Wang Y, Washabaugh MW, Sitrin RD. Visualization of discrete L1 oligomers in human papillomavirus 16 virus-like particles by gel electrophoresis with Coomassie staining. J Virol Methods 2005; 127:133-40.
11. Hansma PK, Cleveland JP, Radmacher M, Walters DA, Hillner PE, Bezanilla M, Fritz M, Vie D, Hansma HG, Prater CB, Massie J, Fukunaga L, Gurley J, Elings V. Tapping mode atomic force microscopy in liquids. Appl Phys Lett 1994; 64:1738-40.
12. Muller DJ, Schabert FA, Buldut G, Engel A. Tapping-mode atomic force microscopy produces faithful high-resolution images of protein surfaces. Biophys J 1995; 68:1681-6.
13. Leatherbarrow R. Grafit Version 5.0. Middlesex, UK: Erithacus Softwares Ltd, 1993-2005.
14. Mangold CM, Unckell F, Werr M, Streeck RE. Analysis of intermolecular disulfide bonds and free sulfhydryl groups in hepatitis B surface antigen particles. Arch Virol 1997; 142:2257-67.
15. Creighton TE. Effects of urea and guanidine-HCl on the folding and unfolding of pancreatic trypsin inhibitor. J Mol Biol 1977; 113:313-28.
16. Thomson JA, Shirley BA, Grimsley GR, Pace CN. Conformational stability and mechanism of folding of ribonuclease T1. J Biol Chem 1989; 264:11614-20.
17. Stirk HJ, Thornton JM, Howard CR. A topological model for of Hepatitis B surface antigen. Intervirology 1992; 33:148-58.
18. Ishimaru D, Maia LF, Maiolino LM, Quesado PA, Lopez PCM, Almeida FCL, Valente AP, Silva JL. Conversion of wild-type p53C core domain into a conformation that mimics a hot-spot mutant. J Mol Biol 2003; 333:443-51.
19. Silva JL, Peng L, Glaser M, Voss EW, Weber G. Effects of hydrostatic pressure on a membrane-enveloped virus: High immunogenicity of the pressure inactivated virus. J Virol 1992; 66:2111-7.
20. Arai M, Kuwajima K. Role of the molten globule state in protein folding. Adv. Protein Chem 2000; 53:209-82.
21. Creighton TE. How important is the molten globule for correct protein folding? Trends Biochem Sci 1997; 22:6-10.
22. Ishimaru D, Lima LM, Maia LF, Lopez PM, Ano Bom AP, Valente AP, Silva JL. Reversible aggregation plays a crucial role on the folding landscape of p53 core domain. Biophys J 2004; 87:2691-700.
23. Dobson CM. The nature and significance of protein folding. In: Pain RH, ed. Mechanism of Protein Folding. New York: Oxford University Press, 2000:1-33.
24. Fersht A. Protein stability. Structure and Mechanism in Protein Science. A Guide to Enzyme Catalysis and Protein Folding. New York: W H Freeman and Co., 1999:508-39.
25. Kuwajima K, Arai M. The molten globule state, the physical picture and biological significance. In: Pain RH. ed. Mechanism of Protein Folding. New York: Oxford University Press, 2000:139-74.
26. Teschke CM, King J. In vitro folding of Phage 22 coat protein with amino acid substitutions that confer in vivo temperature sensitivity. Biochemistry 1995; 34:6815-26.
27. Jones BE, Beechem JM, Matthews CR. In vitro folding of Phage 22 coat protein with amino acid substitutions that confer in vivo temperature sensitivity. Biochemistry 1995; 34:1867-77.
28. Schuman J, Campbell AP, Koganty RR, Longenecker BM. Probing the conformational and dynamical effects of -O-glycosylation within the immunodominant region of a MUC1 peptide tumor antigen. J Peptide Res 2003; 61:91-108.
29. Irazoqui FJ, Sendra VG, Lardone RD, Nores GA. Immune response to Thomas-Frieenreich disaccharide and glycan engineering. 2005; 83:405-12.
30. Buck CB, Thompson CD, Pang YYS, Lowy DR, Schiller JT. Maturation of papillomavirus capsids. J Virol 2005; 79:2839-46.
31. Zhao Q, Wu S, Manger W, Gadam S. 2002. Process for making human papillomavirus virus-like particles with improved properties. US patent 6,436,402.
32. Odegard AL, Chandran K, Liemann S, Harrison SC, Nibert ML. Disulfide bonding among [micro]1 trimers in mammalian reovirus outer capsid: A late and reversible step in virion morphogenesis. J Virol 2003; 77:5389-400.
33. Wootton SK, Yoo D. Homo-oligomerization of the porcine reproductive and respiratory syndrome virus nucleocapsid protein and the role of disulfide linkages. J Virol 2003; 77:4546-57.
34. Gilbert RJC, Beales L, Blond D, Simon MN, Lin BY, Chisari FV, Stuart DI, Rowland DJ. Hepatitis B small surface antigen particles are octahedral. Proc Natl Acad Sci USA 2005; 102:14783-8.